Next Article in Journal
A Multimodal MRI-Based Model for Colorectal Liver Metastasis Prediction: Integrating Radiomics, Deep Learning, and Clinical Features with SHAP Interpretation
Previous Article in Journal
Synchronous Ovarian Sertoli–Leydig Cell and Clear Cell Papillary Renal Cell Tumors: A Rare Case Without Mutations in Cancer-Associated Genes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Brief Report

Using Audit to Improve End-of-Life Care in a Tertiary Cancer Centre †

1
Cork University Hospital, Wilton, T12 DC4A Cork, Ireland
2
Marymount University Hospital and Hospice, T12 A710 Cork, Ireland
3
Cancer Research@UCC, University College Cork, T12 XF62 Cork, Ireland
*
Authors to whom correspondence should be addressed.
This manuscript is an extension of work previously presented as a poster at the European Society of Medical Oncology Congress, Madrid, Spain, 20–24 October 2023 (Poster number 1597, Ann. Oncol., 34:S887-8).
These authors contributed equally to this work.
Curr. Oncol. 2025, 32(8), 430; https://doi.org/10.3390/curroncol32080430
Submission received: 27 June 2025 / Revised: 28 July 2025 / Accepted: 29 July 2025 / Published: 30 July 2025
(This article belongs to the Section Palliative and Supportive Care)

Simple Summary

Many people with cancer die in hospitals, so it is important that they receive the best possible care at the end of life. In 2021, we found several problems in how dying patients were cared for in our hospital, including poor communication, lack of emotional or spiritual support, and limited documentation. To address this, we introduced a care planning form, a checklist, and staff training to improve how we support dying patients and their families. This follow-up study looked at whether these changes led to a measurable improvement. We found that care improved in domains such as communication, symptom control, and referral for spiritual support. The simple use of a care checklist was linked to higher quality ratings for end-of-life care. Our findings show that small, low-cost interventions and regular review can make a big difference in how patients are supported at the end of life. This model could help other hospitals improve care, too.

Abstract

High-quality end-of-life care (EoLC) is a critical yet often underemphasised component of oncology care. Several shortcomings in the delivery of EoLC for oncology patients in our centre during the COVID-19 pandemic were identified in our initial 2021 audit. In 2022, we introduced a care of dying patients proforma, an EoLC quality checklist, targeted education and training for staff, and an expanded end-of-life (EoL) committee. This re-audit aimed to review how these changes impacted on the care received by patients in a tertiary cancer centre. A second retrospective re-audit of patients who died between 11 July 2022 and 30 April 2023 was performed to assess quality of EoLC using the Oxford Quality indicators. A total of 72 deaths occurred over the audit period. Quality of EoLC improved significantly when compared to the initial audit (χ2 (3, n = 138) = 9.75, p = 0.021). Exploration of patients’ wishes was documented in 48.8% and referral to pastoral care was documented in 68.3%, from 24.2% and 10.6%, respectively. The proportion of patients receiving poor EoLC reduced from 21.2% to 8.3%. Our study demonstrates the benefits of simple interventions, the importance of re-audit, and the role of ongoing interdisciplinary commitment to improving EoLC for our patients.

1. Introduction

Cancer is the leading cause of death in Ireland, accounting for 29% of all deaths in 2023 [1]. Many of these deaths occur in an acute hospital setting where increasing interventionalist treatment options can distract from end-of-life care (EoLC). EoLC refers to the care provided to patients in the final days to weeks of life, encompassing symptom control, communication, emotional support, and care planning. It should therefore be a core priority for oncology teams, with multidisciplinary palliative care support [2,3,4], to deliver high-quality, person-centred care to patients in the last days of their lives. Despite this, numerous studies internationally, including our audit, have highlighted inadequacies in the care experienced by patients and their families towards the end of life [5,6,7,8,9,10,11,12].
Clinical audit is the cornerstone of quality improvement in healthcare, providing a systematic method to evaluate and enhance care delivery. In the context of palliative care, audits are particularly valuable as they help identify gaps in symptom control, communication, and patient-centred care, all of which profoundly impact patients and families. While not yet universally routine, auditing in palliative care is increasingly recognised as essential to improving outcomes and guiding service development.
Pandemics expose vulnerabilities and magnify inequalities. The COVID-19 pandemic and a concurrent cyberattack led to significant challenges in the provision of cancer care (including EoLC) in Ireland [13]. These concerns led to an initial audit examining the quality of EoLC for all patients who died under our care in 2021 (n = 66). Deficits identified included inadequate communication with families, limited offering of pastoral care support, and lack of exploration of what was important for patients at EoL [5]. Our results were concordant with the findings of other studies [14,15], including the ‘Time to Reflect Survey’ by the Irish Hospice Foundation, in which 64% of 2200 respondents reported that their experience of the death of a loved one was impacted by the pandemic [16].
In response to our initial audit in July 2022, we introduced a care of dying patients proforma (Appendix A, Figure A1), an EoLC co-ordinator and quality checklist, and expanded our EoL committee to include Non-Consultant Hospital Doctors (NCHDs). Didactic staff education sessions for medical oncology NCHDs and nursing staff on our inpatient ward were provided by our specialist palliative care team on topics related to EoLC. This report outlines the findings of this repeat audit, which aimed to evaluate whether the introduction of structured tools and staff education improved the quality of EOLC for patients in a tertiary cancer centre.

2. Materials and Methods

This was a retrospective re-audit performed at a tertiary cancer centre, one of eight National Cancer Control Programme-affiliated cancer centres and a European Society of Medical Oncology (ESMO)-designated centre of Integrated Oncology and Palliative Care. Inpatient cancer care is provided on a 33-bed ward with five single, one 4-bed, and four 6-bed areas. Specialist palliative care is provided by a consultant-led team, with a registrar and clinical nurse specialists. The Hospital EoL Committee, with representation from medical oncology, palliative care, nursing, pastoral care, and hospital administration, meet monthly to provide oversight for matters involving EoLC and has responsibility for re-audit through our EoLC coordinator.
We identified all patients who died while hospitalised under the care of the medical oncology service between 11 July 2022 and 30 April 2023. Patients’ physical and electronic records were reviewed. Data on the quality of EoLC delivered during their final hospitalisation were collected and managed using Microsoft Excel. Auditing was conducted by a single trained auditor (C.D.M.), with oversight from the EoLC coordinator and the hospital’s EoL committee.
Quality of EoLC was assessed using the Oxford Quality indicators for mortality review (Figure 1) [17], a tool based on UK National Audit of Care at the End of Life audit tools and designed for routine mortality review in clinical practice. It comprises five domains: recognising the possibility of imminent death, communication with the dying person, communication with families and others, involvement in the decision making, and individualised plan of care. Lack of specific documentation in the patient chart was interpreted as absence of a domain, in keeping with standard audit methodology. No significant missing data was observed. An overall score for EoLC was assigned on a numerical scale from 1 (very poor) to 5 (excellent). This tool was chosen for the initial audit as it is designed for routine mortality review in clinical practice.
Patient demographics, the overall quality of EoLC, and the individual domains of EoLC were compared to the initial audit cohort. Chi-squared tests were used to determine statistical significance for categorical variables. Statistical analysis was performed using SPSS v29. Ethical approval was granted by the Hospital Quality and Patient Safety Department (approval number CUH-AUD-2022/018). Informed consent was not required as this was a retrospective medical chart review. Preliminary findings from this audit were previously presented in part as a poster at the European Society of Medical Oncology Congress 2023 (Poster 1597) [18].

3. Results

We identified 72 patients (41 female, 31 male) who died under the care of the medical oncology service. The median age at death was 65 years [range 23–89]. The median length of an admission resulting in death was 12 days [range 0–118]. A total of 62 deaths occurred on inpatient wards, 6 in the emergency department, and 4 in the intensive care or high-dependency units.
The risk of imminent death was documented for 68 patients (94.4%). This risk was communicated to 53 patients (73.6%) and 63 of their families (87.5%), increases from the prior audit of 17.7% and 4.7%, respectively. “Do not attempt cardiopulmonary resuscitation” (DNACPR) orders were completed for 66 patients (91.6%). Unnecessary interventions and investigations were discontinued appropriately in 59 cases (81.9%).
Symptom assessments were documented for 65 patients (90.2%). A total of 58 patients (80.5%) received specialist inpatient palliative care input. Exploration of what was important to the patient and their family was noted in 33 cases (45.8%) and pastoral care or faith advisor input was offered in 42 (58.3%), numerical increases of 21.6% and 47.7%, respectively. All domains, except documentation of risk of imminent death, demonstrated a numerical increase following our interventions (see Figure 2). No significant missing data were observed for key domains.
The mean quality of EoLC was very good (mean = 4.0). A chi-square test showed a statistically significant improvement in EoLC quality scores in the re-audit compared to the initial audit (χ2 (3, n = 138) = 9.75, p = 0.021). The strength of association was small to moderate (Cramér’s V = 0.266). The most frequently received level of care was excellent (i.e., the mode was 5, excellent, n = 28). No patient was assessed to have received very poor (score = 1) EoLC, and the proportion of patients receiving poor (score = 2) EOLC decreased (8.3% vs. 21.2%). The care of dying patients guidance proforma was employed in 42 cases (58.3%). The use of the EoLC proforma was associated with significantly higher quality scores, χ2 (3, n = 70) = 40.21, p < 0.001, indicating a strong positive impact (Cramér’s V = 0.758). Overall, the results recorded using the Oxford scale of 1–5 were as follows: very poor (1): 0, poor (2): 6, satisfactory (3): 15, good (4): 23, and excellent (5): 28.

4. Discussion

This audit found significant improvements in the quality of EoLC for patients in a tertiary cancer centre following the implementation of structured interventions. Use of the care of dying patients proforma was associated with a statistically significant improvement in the quality of EoLC, highlighting it as an effective tool to improve EoLC. Our findings align with prior studies where a similar benefit to the use of proformas or simple interventions, particularly with respect to improved documentation, was observed [17,19,20,21,22,23].
Our results also further validate the use of the Oxford indicators as an audit tool for assessing quality of EoLC at mortality review. The improvement we have seen between audit cycles is consistent with the experience in Oxford University Hospitals, where 3 years of re-audit with this tool have seen scores for the EoL phase of mortality review increase year-on-year [17].
The majority of patients under our care received good or excellent EoLC. Despite numerical improvements in the proportion of patients documented to have been offered pastoral care or had what was important to them explored, these remain areas of relative weakness compared to other domains of EoLC. The role of pastoral care in improving the quality of dying is well recognised [24,25], and continued further prioritisation of this is needed.
The role of didactic education initiatives for healthcare staff in improving EoLC requires further study, particularly as we did not include an assessment of staff experiences. A 2023 systemic review by Bainbridge and colleagues noted that while education interventions can increase health practitioners’ confidence in aspects of EoLC, more objective outcomes were mixed [26]. High-quality EoLC should be everyone’s business. This means that the target audience for teaching is everyone, from frontline clinicians to ward receptionists, catering, porters, and patients and their carers. Diverse teaching and educational strategies are needed to suit these varying roles, with different requirements of knowledge and practical competency. Communication is an especially important skill for healthcare staff to develop in dealing with patients and their families at EoL, and more focused, simulation-based sessions have been shown to improve communication skills in addressing EoL subjects [27]. This may, therefore, be a more effective approach to staff education.
This study has several limitations. Data collection was performed retrospectively and was limited to what was documented in patient records. Actions such as offering pastoral care or communicating with families may occur more frequently than is seen here but lack documentation. Our study also does not capture other important outcomes, such as the experiences of patients’ families or the impact of death and dying on healthcare staff. Doctors, for example, often feel unprepared or unsupported when providing EoLC, which can cause significant emotional distress [28,29].
High-quality EoLC for patients with cancer is complex and multidisciplinary. It is therefore crucial that education and training in delivering EoLC is emphasised to improve continuing professional development and competency for staff at all levels. This study provides a template for how simple interventions, re-audit, and a multidisciplinary approach can be the first step in creating an environment where good-quality EoLC is valued. Through our EoL committee, we are committed to ongoing audit and quality improvement of EoLC. We plan to enhance our educational strategies by surveying junior doctors to tailor content.

5. Conclusions

This work highlights care needs and quality improvements that extend beyond disease-modifying treatments, emphasising person-centred EoLC in oncology. Simple, low-cost interventions, such as care planning proformas and structured education, can meaningfully improve EoLC in oncology. Continued commitment to audit cycles and multidisciplinary collaboration is essential. These findings are relevant not only in academic settings but also for broader clinical practice, where scalable models for improving EoLC are urgently needed.
The difficulties experienced during the COVID-19 pandemic served as the catalyst for our audits and interventions. Climate change is anticipated to make natural disasters, extreme weather events, and pandemics more common [30,31]. The COVID-19 pandemic and analysis of other natural disasters have shown that these events can have profound impacts on EoLC [32]. It is, therefore, essential that we apply our learnings here to future scenarios.

Author Contributions

Conceptualization, All authors; methodology, C.D.M. and S.O.; formal analysis, C.D.M.; investigation, C.D.M., E.C. and M.L.; data curation, C.D.M.; writing—original draft preparation, C.D.M.; writing—review and editing, All authors; visualization, C.D.M.; supervision, S.O. and M.J.O. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Ethical approval was granted by the Cork University Hospital Quality and Patient Safety Department on 3 March 2022 (approval number CUH-AUD-2022/018).

Informed Consent Statement

Informed consent was not required as this study involved a retrospective audit of anonymised patient records and did not involve direct patient contact or intervention.

Data Availability Statement

The original data presented in this study are openly available in FigShare at https://doi.org/10.6084/m9.figshare.29456471.v1.

Acknowledgments

The authors would like to thank the end-of-life committee members and ward staff for their support in implementing and sustaining our quality improvement initiatives.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
EoLEnd-of-life
EoLCEnd-of-life care
ESMOEuropean Society of Medical Oncology
NCHDNon-consultant Hospital Doctor

Appendix A

Figure A1. CUH Care of the Dying Patient Guidance proforma.
Figure A1. CUH Care of the Dying Patient Guidance proforma.
Curroncol 32 00430 g0a1

References

  1. Central Statistics Office. Vital Statistics Yearly Summary: 2023; Central Statistics Office: Dublin, Ireland, 2024; Online ISSN 2009-5333; Available online: https://www.cso.ie/en/releasesandpublications/ep/p-vsys/vitalstatisticsyearlysummary2023/ (accessed on 12 May 2025).
  2. Hui, D.; Bruera, E. Integrating palliative care into the trajectory of cancer care. Nat. Rev. Clin. Oncol. 2016, 13, 159–171. [Google Scholar] [CrossRef]
  3. Chen, S.T.; Chen, S.C.; Lee, H.J.; Chen, C.H. Associations between palliative-care consultations and end-of-life quality in cancer patients’ last 6 months. Support. Care Cancer 2024, 32, 606. [Google Scholar] [CrossRef]
  4. Hua, M.; Guo, L.; Ing, C.; Lackraj, D.; Wang, S.; Morrison, R.S. Specialist palliative care use and end-of-life care in patients with metastatic cancer. J. Pain Symptom Manag. 2024, 67, 357–365. [Google Scholar] [CrossRef]
  5. Carroll, H.K.; Broderick, A.; McCarthy, O.; Bambury, R.M.; Power, D.G.; Collins, D.C.; Connolly, R.M.; Noonan, S.A.; Collins, D.; Cunningham, E.; et al. Room to Improve: An Audit of In-Hospital End-of-Life Care for Oncology Patients in a Tertiary Cancer Centre in Ireland During the COVID-19 Pandemic. OMEGA-J. Death Dying 2023. [Google Scholar] [CrossRef] [PubMed]
  6. Neuberger, J.; Guthrie, C.; Aaronovitch, D. More Care, Less Pathway: A Review of the Liverpool Care Pathway; Department of Health and Social Care: London, UK, 2013. Available online: https://www.gov.uk/government/publications/review-of-liverpool-care-pathway-for-dying-patients (accessed on 12 May 2025).
  7. Parker, K.E.; Gerken, K.; Huckaby, A.P.; Gutek, A.; Freytag, A.; Buderer, N.; Rice, M.R.; Craig, M.E.; Cacciotti, M.; Stausmire, J.M. Collaboration of an Obstetrical Residency Program With a Community Hospice/Bereavement Agency to Implement an Obstetrician Specific Educational Curriculum to Improve Care to Bereaved Families and Support Staff During Difficult Delivery Situations. Am. J. Hosp. Palliat. Med. 2025. [Google Scholar] [CrossRef] [PubMed]
  8. Salins, N.; Rao, K.; Damani, A.; Bhatnagar, S.; Simha, S. Palliative and end-of-life care initiatives for people dying from cancer in India: A narrative review. Ecancermedicalscience 2024, 18, 1822. [Google Scholar] [CrossRef] [PubMed]
  9. Goombs, M.; Mah, K.; Namisango, E.; Luyirika, E.; Mwangi-Powell, F.; Gikaara, N.; Chalklin, L.; Rydall, A.; Zimmermann, C.; Hales, S.; et al. The quality of death and dying of patients with advanced cancer in hospice care in Uganda and Kenya. Palliat. Support. Care 2024, 22, 1169–1178. [Google Scholar] [CrossRef]
  10. Shutoh, M.; Morita, T.; Aoyama, M.; Kizawa, Y.; Shima, Y.; Miyashita, M. Congruence between preferred and actual place of death and its association with quality of death and dying in advanced cancer patients: A nationwide survey in Japan. PLoS ONE 2025, 20, e0320541. [Google Scholar] [CrossRef]
  11. Lin, H.; Ni, P.; Wu, B.; Liao, J.; Fu, J. The congruence between the preferred and actual places of death among terminal cancer patients in China. Front. Psychol. 2024, 15, 1382272. [Google Scholar] [CrossRef]
  12. Videbech, N.M.; Valentin, J.B.; Knudsen, S.V.; Vestergaard, A.H.; Vestergaard, M.; Rasmussen, T.R.; Tipsmark, L.S.; Johnsen, S.P.; Neergaard, M.A.; Simoni, A.H. Disparity in health care in end-of-life among patients with lung cancer and pre-existing mental disorders: A nationwide cohort study. Palliat. Med. 2025, 39, 803–813. [Google Scholar] [CrossRef]
  13. O’Reilly, S.; Carroll, H.K.; Murray, D.; Burke, L.; McCarthy, T.; O’Connor, R.; Kilty, C.; Lynch, S.; Feighan, J.; Cloherty, M.; et al. Impact of the COVID-19 pandemic on cancer care in Ireland–Perspectives from a COVID-19 and Cancer Working Group. J. Cancer Policy 2023, 36, 100414. [Google Scholar] [CrossRef]
  14. Avazeri, A.; Bonin, J.; Maneval, A.; Vorilhon, P. Announcements of Death During the COVID-19 Pandemic: A Qualitative Study of Family Experiences. Health Expect. 2025, 28, e70221. [Google Scholar] [CrossRef]
  15. Russell, L.; Howard, R.; Street, M.; Johnson, C.E.; Berry, D.; Flemming-Judge, E.; Brean, S.; William, L.; Considine, J. Cancer decedents’ hospital end-of-life care documentation: A retrospective review of patient records. J. Palliat. Care 2025, 40, 168–175. [Google Scholar] [CrossRef]
  16. Coughlan, H.; Keegan, O.; Time to Reflect: National Survey Findings. Dublin, Ireland: Irish Hospital Foundation. 2022. Available online: https://hospicefoundation.ie/our-supports-services/advocacy-research/research/time-to-reflect/ (accessed on 12 May 2025).
  17. Miller, M.; Yates, S.; Lewis, D.; Lowney, A. Help for non-specialists assessing EOLC. BMJ Support. Palliat. Care 2022, 14, e3038–e3039. [Google Scholar] [CrossRef]
  18. Moloney, C.; Carroll, H.K.; Cunningham, E.; Lyons, M.; Nuzum, D.; Bambury, R.M.; Collins, D.C.; Connolly, R.M.; Iqbal, S.; Noonan, S.A.; et al. 1579P Improving in-hospital end-of-life care (EOLC) for oncology patients in a tertiary cancer centre. Ann. Oncol. 2023, 34, S887–S888. [Google Scholar] [CrossRef]
  19. Kennedy, A.C.; Jones, D.A.; Eastwood, G.M.; Wellington, D.; See, E.; Lewis, J.E. Improving the quality of family meeting documentation in the ICU at the end of life. Palliat. Care Soc. Pract. 2022, 16, 26323524221128838. [Google Scholar] [CrossRef] [PubMed]
  20. Epstein, A.S.; Riley, M.; Nelson, J.E.; Bernal, C.; Martin, S.; Xiao, H. Goals of care documentation by medical oncologists and oncology patient end-of-life care outcomes. Cancer 2022, 128, 3400–3407. [Google Scholar] [CrossRef] [PubMed]
  21. Zhang, B.; Nilsson, M.E.; Prigerson, H.G. Factors important to patients’ quality of life at the end of life. Arch. Intern. Med. 2012, 172, 1133–1142. [Google Scholar] [CrossRef]
  22. Huang, H.L.; Chen, P.J.; Mori, M.; Suh, S.Y.; Wu, C.Y.; Peng, J.K.; Shih, C.Y.; Yao, C.A.; Tsai, J.S.; Chiu, T.Y.; et al. Improved symptom change enhances quality of dying in patients with advanced cancer: An East Asian cross-cultural study. Oncologist 2024, 29, e553–e560. [Google Scholar] [CrossRef]
  23. Driller, B.; Talseth-Palmer, B.; Hole, T.; Strømskag, K.E.; Brenne, A.T. Cancer patients have a reduced likelihood of dying in hospital with advance care planning in primary health care and a summarizing palliative plan: A prospective controlled non-randomized intervention trial. Scand. J. Prim. Health Care 2024, 42, 471–482. [Google Scholar] [CrossRef]
  24. Karim, A.; Thakur, P.; Ramani, D.P.; Fernandes, D.; Miriyala, R.; Vadgaonkar, R.A.; Viswanath, V. An Audit Cycle to Evaluate the Improvement in Documentation of Breathlessness and Non-Pharmacological Interventions in Palliative Care Services. Indian J. Palliat. Care 2025, 1–5. [Google Scholar] [CrossRef]
  25. D’Andria Ursoleo, J.; Calì, C.; Losiggio, R.; Limone, V.; Mucci, E.; Monaco, F. Spiritual care in palliative medicine and end of life: A bibliometric network analysis. J. Palliat. Med. 2025, 28, 265–279. [Google Scholar] [CrossRef] [PubMed]
  26. Bainbridge, D.; Bishop, V.; Myers, J.; Marshall, D.; Stajduhar, K.; Seow, H. Effectiveness of training programs about a palliative care approach: A systematic review of intervention trials for health care professionals. J. Palliat. Med. 2023, 26, 564–581. [Google Scholar] [CrossRef] [PubMed]
  27. Harnischfeger, N.; Rath, H.M.; Alt-Epping, B.; Brand, H.; Haller, K.; Letsch, A.; Rieder, N.; Thuss-Patience, P.; Bokemeyer, C.; Bergelt, C.; et al. Effects of a communication training for oncologists on early addressing palliative and end-of-life care in advanced cancer care (PALLI-COM): A randomized, controlled trial. ESMO Open 2022, 7, 100623. [Google Scholar] [CrossRef]
  28. Bharmal, A.; Morgan, T.; Kuhn, I.; Wee, B.; Barclay, S. Palliative and end-of-life care and junior doctors: A systematic review and narrative synthesis. BMJ Support. Palliat. Care 2019, 12, e862–e868. [Google Scholar] [CrossRef]
  29. Tan, S.Y.; Tan, J.R.; Ong, Y.T.; Ng, Y.; Sinnathamby, A.; Abdul Hamid, N.A.; Ong, S.Y.; Krishna, L.K. The impact of death and dying on surgeons in a tertiary cancer centre in Singapore. BMC Surg. 2025, 25, 196. [Google Scholar] [CrossRef]
  30. Baker, R.E.; Mahmud, A.S.; Miller, I.F.; Rajeev, M.; Rasambainarivo, F.; Rice, B.L.; Takahashi, S.; Tatem, A.J.; Wagner, C.E.; Wang, L.F.; et al. Infectious disease in an era of global change. Nat. Rev. Microbiol. 2022, 20, 193–205. [Google Scholar] [CrossRef]
  31. Weadick, C.S.; Keogh, R.J.; Carroll, H.K.; Boldrin, S.; Mulroe, E.; Murphy, L.; Sheils, B.; Barry, A.; O’Reilly, S. Climate toxicity: An increasingly relevant clinical issue in Cancer Care. J. Cancer Policy 2023, 35, 100410. [Google Scholar] [CrossRef]
  32. Kelly, M.; Mitchell, I.; Walker, I.; Mears, J.; Scholz, B. End-of-life care in natural disasters including epidemics and pandemics: A systematic review. BMJ Support. Palliat. Care 2021, 13, 1–14. [Google Scholar] [CrossRef]
Figure 1. Oxford Quality indicators for mortality review.
Figure 1. Oxford Quality indicators for mortality review.
Curroncol 32 00430 g001
Figure 2. Documentation of domains of EoLC pre- and post-intervention.
Figure 2. Documentation of domains of EoLC pre- and post-intervention.
Curroncol 32 00430 g002
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Moloney, C.D.; Carroll, H.K.; Cunningham, E.; Nuzum, D.; Lyons, M.; Bambury, R.M.; Collins, D.C.; Connolly, R.M.; O'Donovan, P.; Sumugat, R.; et al. Using Audit to Improve End-of-Life Care in a Tertiary Cancer Centre. Curr. Oncol. 2025, 32, 430. https://doi.org/10.3390/curroncol32080430

AMA Style

Moloney CD, Carroll HK, Cunningham E, Nuzum D, Lyons M, Bambury RM, Collins DC, Connolly RM, O'Donovan P, Sumugat R, et al. Using Audit to Improve End-of-Life Care in a Tertiary Cancer Centre. Current Oncology. 2025; 32(8):430. https://doi.org/10.3390/curroncol32080430

Chicago/Turabian Style

Moloney, Conor D., Hailey K. Carroll, Elaine Cunningham, Daniel Nuzum, Mairead Lyons, Richard M. Bambury, Dearbhaile C. Collins, Roisín M. Connolly, Paula O'Donovan, Renelyn Sumugat, and et al. 2025. "Using Audit to Improve End-of-Life Care in a Tertiary Cancer Centre" Current Oncology 32, no. 8: 430. https://doi.org/10.3390/curroncol32080430

APA Style

Moloney, C. D., Carroll, H. K., Cunningham, E., Nuzum, D., Lyons, M., Bambury, R. M., Collins, D. C., Connolly, R. M., O'Donovan, P., Sumugat, R., Iqbal, S., Noonan, S. A., Power, D. G., Lowney, A. C., O’Reilly, S., & O'Leary, M. J. (2025). Using Audit to Improve End-of-Life Care in a Tertiary Cancer Centre. Current Oncology, 32(8), 430. https://doi.org/10.3390/curroncol32080430

Article Metrics

Back to TopTop